GlaxoSmithKline PLC
NYSE:GSK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
GlaxoSmithKline PLC (GSK) under the Base Case is USD per share.
Compared with the current market price of 47.76 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What GlaxoSmithKline Does
GlaxoSmithKline, or GSK, is a global drug maker focused on prescription medicines and vaccines. It develops and sells treatments for areas such as respiratory disease, HIV, immunology, oncology, and infectious disease, along with vaccines for children, adults, and travel-related prevention. Its main customers are governments, health systems, hospitals, doctors, and pharmacies that buy and distribute its products to patients.
- Headquarters
- United Kingdom UK
- Employees
- 90 096
- IPO date
- May 22, 1972
GlaxoSmithKline has no economic moat
Protection rests on individual medicines rather than a lasting barrier around GSK as a whole: patents protect particular drugs, while competing treatments can still reach customers. Generic competition in established medicines shows why successful products do not guarantee lasting protection across the business.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
GSK reconfirmed its 2026 outlook as specialty-led momentum continued, while management highlighted pipeline expansion and ongoing launch, vaccine-market and HIV-development uncertainties.
Open the earnings call- EPS
- GBX 0.55
- Expected
- GBX 0.53
- Surprise
- +3.0%
- Stock, next trading day
- −1.0%
Past 12 months
Continue GSK Research
Decided on GlaxoSmithKline? Get an email when GSK reaches the price you’d buy at. Free with an account.
Other GlaxoSmithKline listings
What is the Intrinsic Value of one GSK stock?
The intrinsic value for
GlaxoSmithKline PLC (GSK) under the Base Case is USD.
Is GSK stock undervalued or overvalued?
Compared with the current market price of 47.76 USD, the stock appears .